Cytokinetics, IncorporatedCYTKNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-399.80M
↓ 153% below average
Average (9y)
$-158.05M
Historical baseline
Range
High:$35.39M
Low:$-415.75M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-399.80M | +3.8% |
| 2023 | $-415.75M | -33.7% |
| 2022 | $-310.85M | -62.4% |
| 2021 | $-191.39M | -8975.1% |
| 2020 | $-2.11M | +97.7% |
| 2019 | $-93.53M | +8.4% |
| 2018 | $-102.10M | +2.4% |
| 2017 | $-104.64M | -395.7% |
| 2016 | $35.39M | +718.9% |
| 2015 | $4.32M | - |